These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 29855145)

  • 1. Antinuclear and antiretinal antibodies in uveitis associated with active and latent tuberculosis.
    La Distia Nora R; Ten Berge JC; Rothova A; Schreurs MW
    Acta Ophthalmol; 2018 Aug; 96(5):e659-e660. PubMed ID: 29855145
    [No Abstract]   [Full Text] [Related]  

  • 2. No Evidence for Circulating Retina Specific Autoreactive T-cells in Latent Tuberculosis-associated Uveitis and Sarcoid Uveitis.
    Schrijver B; Hardjosantoso H; Ten Berge JCEM; Schreurs MWJ; Van Hagen PM; Brooimans RA; Rothova A; Dik WA
    Ocul Immunol Inflamm; 2021 Jul; 29(5):883-889. PubMed ID: 31913737
    [No Abstract]   [Full Text] [Related]  

  • 3. Autoreactive T Cells in Immunopathogenesis of TB-Associated Uveitis.
    Tagirasa R; Parmar S; Barik MR; Devadas S; Basu S
    Invest Ophthalmol Vis Sci; 2017 Nov; 58(13):5682-5691. PubMed ID: 29101404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunological aspects of tuberculosis uveitis pathogenesis].
    Panova IE; Tarasova LN; Teplova SN; Varnavskaia NG
    Probl Tuberk; 1997; (4):51-3. PubMed ID: 9333821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of an immune response to Mycobacterium tuberculosis in patients with chronic posterior uveitis revisited: utility of the new IGRAs.
    Cordero-Coma M; Calleja S; Torres HE; del Barrio I; Franco M; Yilmaz T; Vivas S; de Morales JG
    Eye (Lond); 2010 Jan; 24(1):36-43. PubMed ID: 19300463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune-mediated tuberculous uveitis - A rare association with papulonecrotic tuberculid.
    Singh PY; Sinha P; Baveja S; Sood A
    Indian J Ophthalmol; 2019 Jul; 67(7):1207-1209. PubMed ID: 31238468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and clinical impact of antiretinal antibodies in uveitis.
    Ten Berge JC; Schreurs MW; Vermeer J; Meester-Smoor MA; Rothova A
    Acta Ophthalmol; 2016 May; 94(3):282-8. PubMed ID: 26748893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antiretinal antibodies (ARA) in patients with endogenous posterior uveitis in indirect immunofluorescence test].
    Kubicka-Trzaska A
    Klin Oczna; 2004; 106(1-2):45-9. PubMed ID: 15218764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical signs of uveitis associated with latent tuberculosis.
    Ang M; Hedayatfar A; Zhang R; Chee SP
    Clin Exp Ophthalmol; 2012; 40(7):689-96. PubMed ID: 22299676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the utility of QuantiFERON-TB gold in tube and measurement of IFNgamma release by peripheral mononuclear cells in response to different mycobacterium antigen in the work-up of patients with uveitis.
    Makhoul D; Mascart F; Schandene L; Willermain F; Caspers L
    Bull Soc Belge Ophtalmol; 2011; (317):61-2. PubMed ID: 21560863
    [No Abstract]   [Full Text] [Related]  

  • 11. Antinuclear autoantibodies in uveitis.
    Hundert I; Bakimer R; Amital-Teplizki H; Slor H; Yassur Y; Palestine A; Nussenblatt RB; Shoenfeld Y
    Clin Exp Rheumatol; 1989; 7(3):237-41. PubMed ID: 2788056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of methotrexate in resolving ocular inflammation after specific therapy for presumed latent syphilitic uveitis and presumed tuberculosis-related uveitis.
    Sahin O; Ziaei A
    Retina; 2014 Jul; 34(7):1451-9. PubMed ID: 24531737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antinuclear antibody profiling in uveitis.
    Ten Berge JC; Groen-Hakan F; Rothova A; Schreurs MWJ
    Acta Ophthalmol; 2018 Aug; 96(5):e660-e661. PubMed ID: 29461672
    [No Abstract]   [Full Text] [Related]  

  • 14. My Right Eye Looks Red and Angry.
    Wadhwani M; Chopra K; Manika M
    J Pediatr Ophthalmol Strabismus; 2019 May; 56(3):139. PubMed ID: 31116857
    [No Abstract]   [Full Text] [Related]  

  • 15. [Autoantibodies in patients with uveitis of various etiologies].
    Teplinskaia LE; Bulanova TD; Zaĭtseva NS; Kaliberdina AF; Katsnel'son LA
    Vestn Oftalmol; 1984; (2):40-3. PubMed ID: 6719697
    [No Abstract]   [Full Text] [Related]  

  • 16. Duration of anti-tubercular therapy in uveitis associated with latent tuberculosis: a case-control study.
    Ang M; Hedayatfar A; Wong W; Chee SP
    Br J Ophthalmol; 2012 Mar; 96(3):332-6. PubMed ID: 21719564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis of ocular tuberculosis: New observations and future directions.
    Basu S; Elkington P; Rao NA
    Tuberculosis (Edinb); 2020 Sep; 124():101961. PubMed ID: 33010848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycobacterial ocular inflammation: delay in diagnosis and other factors impacting morbidity.
    Patel SS; Saraiya NV; Tessler HH; Goldstein DA
    JAMA Ophthalmol; 2013 Jun; 131(6):752-8. PubMed ID: 23579549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiretinal antibodies in central serous chorioretinopathy: prevalence and clinical implications.
    Ten Berge JCEM; van Dijk EHC; Schreurs MWJ; Vermeer J; Boon CJF; Rothova A
    Acta Ophthalmol; 2018 Feb; 96(1):56-62. PubMed ID: 28444929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serum antiretinal antibodies titres in patients with endogenous posterior uveitis in 12 months follow-up period].
    Kubicka-Trzaska A
    Klin Oczna; 2002; 104(3-4):226-30. PubMed ID: 12608306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.